Work

Abstract 5562: Utility of circulating biomarkers as outcome predictors in metastatic colorectal cancer and recurrent glioblastoma multiforme patients treated with bevacizumab/sorafenib

Year: 2012

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2012-5562

Authors: Jacqueline M. Lafky, S. Keith Anderson, Bruce W. Morlan, Garth D. Nelson, Xiomara W. Carrero, Shaji Kumar, John T. Reynolds, Philip J. Stella, Shaker R. Dakhil, William S. Loui, Steven R. Alberts, Patrick J. Flynn, Howard M. Gross, Kurt A. Jaeckle, Jan C. Buckner, Evanthia Galanis, Axel Grothey

Institutions: Mayo Clinic, Medtronic (Germany), Trinity Health Michigan, University of Hawaii Cancer Center, Mayo Clinic in Florida

Language: English

Topic: Colorectal Cancer Treatments and Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1977042007

Cites:

Cited by:

Related to: 10